Financial Navigation Program for Improving Financial Toxicity Among Breast Cancer in China
Evaluation of the Financial Navigation Program for Improving Financial Toxicity Among Breast Cancer in China
1 other identifier
interventional
82
1 country
1
Brief Summary
The goal of this study is to access the impact of a financial navigation program on improving financial toxicity among patients with breast cancer in China. The main questions it aims to answer are:
- Does the intervention alleviate participants' financial toxicity?
- Does the intervention enhance participants' cost-related health literacy?
- Does the intervention improve participants' shared decision-making?
- Does the intervention reduce participants' perceived stress? Researchers will compare the financial navigation program with usual oncology care to evaluate its effectiveness. Participants will receive the comprehensive financial navigation, including:
- Needs assessment;
- Cost-related health education, mainly including topics regarding communication of cost, treatment-related cost, health insurance policies, and family support;
- Resource and service referral;
- Personalized counseling.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 17, 2024
CompletedFirst Submitted
Initial submission to the registry
June 26, 2024
CompletedFirst Posted
Study publicly available on registry
July 3, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 11, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
November 17, 2024
CompletedFebruary 27, 2025
June 1, 2024
5 months
June 26, 2024
February 25, 2025
Conditions
Outcome Measures
Primary Outcomes (3)
Financial toxicity
Financial toxicity will be measured with the Comprehensive Score for Financial Toxicity-Functional Assessment of Chronic Illness Therapy Version 2 (COST-FACIT-V2); lower scores (range, 0-44) indicating greater financial toxicity.
Baseline, 1st month and 3rd month since baseline
Material domain of financial toxicity
Material domain of financial toxicity will be measured with 2 items adapted from the Medical Expenditure Panel Survey (MEPS).
1st month and 3rd month since baseline
Behavioral domain of financial toxicity
Behavioral domain of financial toxicity will be measured by employment changes and cost-related nonadherence with 6 items adapted from MEPS and previous literature.
1st month and 3rd month since baseline
Secondary Outcomes (3)
Cost-related health literacy
Baseline, 1st month and 3rd month since baseline
Shared decision-making
Baseline, 1st month and 3rd month since baseline
Perceived stress
Baseline, 1st month and 3rd month since baseline
Study Arms (2)
Financial Navigation
EXPERIMENTALParticipants will receive financial navigation service, including * Needs Assessment: provide a brief introduction of cancer-related FT and assess patients' information needs using a self-made cost-related health literacy questionnaire; * Cost-Related Health Education: mainly include topics regarding communication of cost, treatment-related cost, health insurance policies, and family support; * Resource and Service Referral: promote timely referral to financial assistance programs and clinical professionals when identify unaddressed problems; * Personalized Counseling Module: provide one-on-one counseling for symptom management, cost-related issues, and coping strategies.
Usual Care
ACTIVE COMPARATORParticipants will receive usual care during hospitalization and regular follow-up after discharge. Participants have the freedom to utilize any financial resources, but financial navigators do not offer comprehensive information support. When participants actively inquire about cancer treatment-related costs or financial planning strategies, financial navigators will answer their questions.
Interventions
During hospitalization, participants will receive needs assessment, and one-on-one cost-related health education with a material booklet. Resource and service referral will be delivered face-to-face or by phone when the navigator identifies unaddressed problems. Within three months after discharge, participants will receive monthly follow-up phone calls and personalized counseling via WeChat.
Participants will receive usual oncology care during hospitalization and regular follow-up after discharge. Participants have the freedom to utilize any financial resources, but financial navigators do not offer comprehensive information support.
Eligibility Criteria
You may qualify if:
- Newly diagnosed with breast cancer and undergoing surgery during this admission;
- Female, age 18 years or older;
- Receiving or expected to receive one or more of the following therapies: chemotherapy, radiotherapy, endocrine therapy, targeted therapy, and immunotherapy;
- Eastern Cooperative Oncology Group Performance Status 0-2;
- Provided informed consent to participate in this study.
You may not qualify if:
- Diagnosed with ductal carcinoma in situ (DCIS)
- Presence of any serious psychiatric disorders;
- Cognitive impairments;
- Difficulty in reading, writing, or communicating in Chinese.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Fudan Universitylead
Study Sites (1)
Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality, 200032, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
June 26, 2024
First Posted
July 3, 2024
Study Start
June 17, 2024
Primary Completion
November 11, 2024
Study Completion
November 17, 2024
Last Updated
February 27, 2025
Record last verified: 2024-06
Data Sharing
- IPD Sharing
- Will not share
We do not plan to share individual participant data due to privacy concerns and confidentiality agreements with participants.